LeonaBio Inc. (LONA)
LONA trades on Nasdaq in Health Care, Biotechnology: Biological Products (No Diagnostic Substances). Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$6.43
+4.30% on the day
Market cap
$60.6M
Micro cap
Revenue
Not reported in SEC XBRL data
Net income
Not reported in SEC XBRL data
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.
Profile
| Field | Value |
|---|---|
| Ticker | LONA on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) |
| Country | United States |
| IPO year | 2020 |
| SEC CIK | 0001620463 |
| SEC industry code | Biological Products, (No Diagnostic Substances) |
| Incorporated in | DELAWARE |
Financials
Not reported in SEC XBRL data.
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B3 | 2026-04-02 |
| Latest annual report | 10-K | 2026-03-31 |
| Latest quarterly / interim | 10-Q | 2026-08-14 |
| Latest current report | 8-K | 2026-09-22 |
| Latest proxy | DEFA14A | 2026-05-11 |
Source: SEC EDGAR submissions feed, 464 recent filings. All filings on EDGAR.
Peers in Biotechnology: Biological Products (No Diagnostic Substances)
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| CSBR | Champions Oncology Inc. | $4.90 | -1.08% | $68.2M |
| KLRS | Kalaris Therapeutics Inc. | $2.23 | -1.33% | $53.1M |
| NMRA | Neumora Therapeutics Inc. | $0.3702 | -15.34% | $69.6M |
| INKT | MiNK Therapeutics Inc. | $10.23 | -2.85% | $52.2M |
| BKHA | Black Hawk Acquisition Corporation | $12.48 | -4.00% | $51.8M |
| ELOX | Eloxx Pharmaceuticals Inc. | $12.70 | -8.57% | $51.3M |
| CRBU | Caribou Biosciences Inc. | $0.4700 | -5.41% | $50.4M |
| GRML | Greenland Mines Ltd. | $5.54 | -7.97% | $73.9M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier